Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,928 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Active, Not Recruiting

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

NCT04926818

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Arkansas Childrens Hosp Rsch Inst Little Rock, Arkansas, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • Axiom Clinical Research of Florida Tampa, Florida, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

NCT06141486

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Alabama Neurology Associates- Site Number : 8400115 Homewood, Alabama, United States
  • Perseverance Research Center- Site Number : 8400138 Scottsdale, Arizona, United States
  • Imaging Endpoints- Site Number : 8400050 Scottsdale, Arizona, United States
  • Sutter East Bay Medical Foundation - Berkeley- Site Number : 8400134 Berkeley, California, United States
View all 311 locations
View Trial Details
Active, Not Recruiting

A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)

NCT05925049

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Cambridge, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Glymphatic MRI in Clinically Isolated Syndrome

NCT06274671

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Clinically Isolated Syndrome, +5 more
Locations
  • Royal Devon University Healthcare NHS Foundation Trust Exeter, United Kingdom
  • University of Exeter Exeter, United Kingdom
View Trial Details
Active, Not Recruiting

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

NCT05269004

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arizona, United States
  • MS Center of California Laguna Hills, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France

NCT06157086

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Agen, France
  • Novartis Investigative Site Altkirch, France
View all 49 locations
View Trial Details
Active, Not Recruiting

Obesity and Pediatric Multiple Sclerosis

NCT04593082

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Body Weight, +15 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details

Related conditions